10.1  Insertion of GUS (GFP, YFP) genes to form a fusion protein with a target gene

Tomomichi Fujita and Yuji Hiwatashi

 

1. Strategy

A reporter gene to fuse with a native gene is knocked-in with gene targeting technique. Spatiotemporal regulation of the fusion protein driven by a native promoter can be examined. However, the stability and localization of the fusion protein may be different form the native protein. Especially when similar phenotypes to disruptants are observed in the transformants with the fusion protein, the fusion protein likely have different function, such as dominant negative function, from the native protein. Technique on histochemical immuno staining has long been expected, but is applicable only in protonemata, but not in gametophores and sporophytes.

 

2. Construction and transformation

The uidA (GUS), GFP, and modified YFP genes are used as reporter genes. The reporter gene is fused to either C-terminal or N-terminal end of the targeted gene (Fig. 1). Comparison of localization between C-terminal and N-terminal fusion proteins will give implications for the reliability of the localization, and both constructs should be designed.

 

 

[C-terminal fusion]

GUS + G418 (nptII) :pGUSmutNPTII, pTN83, pTN84, pTN85

GFP + G418 (nptII):pGFPmutNPTII

YFP + G418 (nptII):pCtrnNPTII2

GFP + Hygromycin (hyg) :pYRG2

GFP + Zeocin (zeocin):pHIZ2

 

[N-terminal fusion]

GFP + Zeocin (zeocin):pHIZ3

YFP + G418 (nptII):pCtrnNPTII2

 

Figure 1.  Maps for constructions of C-terminal fusion (a) and N-terminal fusion (b)

 

i) C-terminal GUSGFP, YFPfusion construction (Fig. 1a)

A more than 1 kb genomic DNA fragment of a targeted gene whose 3' end is just before its stop codon is inserted in 5' multicloning site of the vector (Fig. 1a). A method to obtain the genomic sequences are shown in 10.0. The uidA gene becomes the same reading frame as the targeted gene. Another more than 1 kb genomic DNA fragment whose 5' end is the stop codon of the targeted gene is inserted in 3' multicloning site of the vector (Fig. 1a). The size of the homologous genomic DNA fragments can be reduced to 500 bp or less, although the rate of homologous recombination becomes worse.

 

(Example)

1.  Amplify a genomic fragment for the 5' end as mentioned above by PCR. Add restriction sites at the 5' end of primers for cloning. Select restriction sites that do not cut the genomic fragment.

 

2.  After cloning the fragment, confirm the correct insertion and no PCR errors by sequencing, especially for the reading frame.

 

3.  Amplify a genomic fragment for the 3' end as mentioned above by PCR with primers having restriction sites at their 5' ends for the cloning. Select the restriction sites that do not cut a genomic fragment to be cloned. After cloning the fragment, confirm the correct insertion and no PCR errors, especially for the reading frame.

 

4.  Linearize the plasmid by restriction enzymes to excise the DNA fragment for targeting from a vector and transform protoplasts.

 

ii) N-terminal GUSGFP, YFPfusion construction (Fig. 1b)

Three DNA fragments are inserted into a cloning vector (Fig. 1b). At first, a more than 1 kb genomic DNA fragment of a targeted gene whose 3' end is the start ATG is inserted into 5' end of a reporter gene without its start codon. Secondly, a genomic DNA fragment covering a coding region of the targeted gene that starts just after its start codon and that ends at its stop codon is inserted into 3' end of a reporter gene to make a translational fusion product. Finally, a more than 1 kb genomic DNA fragment that starts just after the stop codon of the targeted gene is inserted into 3' end of the nptII cassette.

 

(Example using pHIZ3)

1. Amplify a genomic fragment of 5' untranslated region as mentioned above by PCR. Add restriction sites at the 5' end of primers for cloning. Select restriction sites that do not cut the genomic fragment. After cloning the fragment, confirm the correct insertion and no PCR errors by sequencing, especially for the reading frame.

 

2. Amplify a genomic fragment as mentioned above by PCR with primers carrying SalI and ClaI sites. After cloning the fragment, confirm the correct insertion and no PCR errors, especially for the reading frame.

 

3. Amplify a genomic fragment of 3' untranslated region by PCR with primers having restriction sites for the cloning. Select restriction sites that do not cut the genomic fragment. After cloning the fragment, confirm the correct insertion and no PCR errors by sequencing, especially for the reading frame.

 

4. Linearize the plasmid by restriction enzymes to excise the DNA fragment for targeting from a vector and transform protoplasts.

 

 

3. Selection of transformants with a correct insertion

 

PCR and Southern blot analyses are used to select transformed lines with a correct insertion. PCR is used at the first stage of screening, and then southern analysis is performed. To avoid an unexpected insertion, You definitely need to perform southern hybridization to proceed to further analyses of the transformants.

 

(Example for 3' knock-in)

(1) PCR analyses

1. Extract a genomic DNA from the candidate stable transformants.

 

2. Perform two kinds of PCRs:

 

(first PCR) Perform PCR using primer A and B. Primer A needs to locate at 5' region to the expected 5' recombination site and does not locate in the targeted fragment.

 

(second PCR) Perform PCR using primer B and C. No PCR products will be obtained. If products are amplified, targeting fragments are likely knocked in as a tandem repeat. The tandem insertions often happens in our experimental conditions. To prevent PCR error, confirmation by southern hybridization is necessary.

 

(2) Southern blot analyses

1. Extract genomic DNA by CTAB method from the candidate transformants selected by PCR.

 

2. Digest genomic DNA with restriction enzymes (ex. EcoRI in the figure) and blot to a nylone membrane.

 

3. We usually use two kinds of probes: one locates in genomic region (probe A) and another in uidA to prevent the unexpected insertions that sometimes happen!

 


Appendix

 

A targeting vector for YFP fusion: pCTRN-NPTII 2

 

pCTRN-NPTII 2 carries a modified YFP, called citrine, as a reporter. Citrine shows more decreased pH and halide sensitivity than YFP (Griesbeck et al. JBC 276, 2001). Citrine was kindly provided by Dr. R. Tsien. Place a genomic fragment containing a coding region into EcoRV site to make C-terminal citrine fusion. For N-terminal citrine fusion, BsrGI site is available.

 


Sequence around citrine gene in pCTRN-NPTII 2 (See below)